Thursday, April 3, 2025
HomeTagsBiopharmaceutical

biopharmaceutical

Regnum Signs Agreement with CytoDyn and SevenScore Pharma to Commercialize HIV Drug Leronlimab

Regnum Corp., and SevenScore Pharmaceuticals, LLC ("SevenScore"), announced the assignment of the Commercialization and License Agreement ("CLA") and a related Supply Agreement to commercialize...

GoldenBiotech Announces Results from COVID-19 Trial for Oral New Drug Antroquinonol

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announces that its Phase 2 COVID-19 trial for oral new drug Antroquinonol has achieved 100% recovery...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results – Reduce Amyloid β in Alzheimer’s Disease

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ. The...

Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced...

Renexxion Ireland Announces Issuance of a New US Patent covering Naronapride, a Clinical Stage Potential Best-in-Class Prokinetic Agent for Gastrointestinal disorders

Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced the issuance...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics